Please login to the form below

payer

This page shows the latest payer news and features for those working in and with pharma, biotech and healthcare.

to gain traction in the marketplace after a slow start caused by payer resistance.

J&J’s ponesimiod tops Aubagio in head-to-head MS trial

There is also a looming threat of generic competition to Gilenya and Tecfidera, which could make it harder for new drugs to negotiate access with payers.
TMC rockets on data for twice-yearly cholesterol drug inclisiran

payer resistance.
Novo Nordisk shareholder revolt reaches Europe

At the heart of the dispute are claims that the Danish drugmaker wasn’t completely transparent about the pricing pressure on insulin from healthcare payers in the US.
Tagrisso tops rival drugs on survival in first-line lung cancer

It will also help the company make its case to payers.
Boehringer posts solid first half as business revamp beds in

Boehringer has been trying transfer patients from Spiriva to new combination Spiolto (tiotropium/olodaterol), but has reportedly been encountering payer resistance.

More from news
Approximately 5 fully matching, plus 555 partially matching documents found.

Real-world studies

Regulatory bodies continue to focus on the development of guidelines for standardised use of RWE, as payer interest also grows in using RWE to support a product’s value story. ... By identifying what evidence will support regulators’ and payers’
The evolution of real-world studies

Recognising that, the United Kingdom has sought to position its relatively standardised, single payer healthcare system for use in the generation of RWE.
Why everyone in pharma is bending over backwards to be agile

There are many ‘kicks’ facing the industry: loss of patents, changes in regulatory, political and payer environments, not to mention the competitive pressures of smaller, faster competitors.
Re-imagining content supply chains for a next-gen customer experience in pharma

But foremost, I would say the anticipation of the content volume increasing rapidly as we embark on an increasingly digital and multi-channel communication with our customers (patients, payers or providers).
M&A drivers in healthcare communications

As the stakeholder group has evolved, pharma companies are looking for the most effective ways to inform customers, whether they are patients, healthcare professionals or payers, about the benefits of their

More from intelligence
Approximately 5 fully matching, plus 213 partially matching documents found.

Open Access Consulting appoints new director

In this role, Hurrell oversaw the team’s market access communications offering, supporting clients in the development of value communications materials with the payer as the ultimate end audience, including core ... value dossiers, payer-focused
Claes Buxfeldt joins NDA

He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.
Acumen appoints new strategy director

policy makers, patient representatives, media, regulators and payers.
VCLS appoints Carole Jones to senior market access role

her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... She said: “I am delighted to be part of an
Dr Gopalan Narayanan joins VCLS

interactions with regulators and payers.

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Valid Insight: TRAVELLESS, the Virtual Workshop Solution for Pharma

It’s now easier, faster and more convenient than ever to get the clinical or payer insight you need.
Ashfield to host webinar on Patient Support Programmes on Tuesday 10 October

Patients, payers and healthcare professionals have high expectations for patient support programmes (PSPs).
The Valid Insight visit to Buckingham Palace

In April, it was announced that the Valid Insight team had been awarded the Queen’s Award for Enterprise in International Trade. It was an amazing moment for us all. It was not only a testament to the team’s hard work and indisputable expertise,
Valid Insight wins the Queen’s Most Coveted Award for Enterprise

Valid Insight’s global network of opinion leaders, payers and expert consultants provides the pharmaceutical and life sciences industry with strategic insight and tools to assist with difficult decision making, in
Precision medicine with precision management and precision pricing; ensuring affordability in the cell and gene therapy era

budget in one fell swoop is a problem for payers. If payers want to ensure access to these treatments, there will need to be a change in the cost curve; but ... Performance based annuities over the longer term with payers taking responsibility for